These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23200236)

  • 41. Texture analysis of
    Nakajo M; Jinguji M; Shinaji T; Nakajo M; Aoki M; Tani A; Sato M; Yoshiura T
    Br J Radiol; 2018 Feb; 91(1083):20170546. PubMed ID: 29182373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses.
    Luzzi L; Campione A; Gorla A; Vassallo G; Bianchi A; Biggi A; Terzi A
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):475-9. PubMed ID: 19501523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The feasibility of 18F-fluorodeoxyglucose-positron emission tomography uptake as a prognostic factor for paranasal sinus malignancy.
    Seol JH; Kim J; Lee JD; Lee JG; Yoon JH; Kim CH
    Am J Rhinol Allergy; 2013; 27(2):118-22. PubMed ID: 23562200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.
    Travaini LL; Petralia G; Trifirò G; Ravasi L; Galetta D; Carbone G; Falcini F; Spaggiari L; Bellomi M; Paganelli G
    Lung Cancer; 2008 Sep; 61(3):362-8. PubMed ID: 18358558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of Preoperative
    Ishibashi M; Tanabe Y; Yunaga H; Miyoshi H; Miwa K; Nakamura H; Fujii S; Ogawa T
    Yonago Acta Med; 2019 Mar; 62(1):146-152. PubMed ID: 30962757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
    Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T
    Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of maximum standardized uptake value at fluorine-18 fluorodeoxyglucose positron emission tomography as a complementary T factor in the eighth edition of lung cancer stage classification.
    Kim H; Goo JM; Paeng JC; Kim YT; Park CM
    Lung Cancer; 2019 Aug; 134():151-157. PubMed ID: 31319974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of 18-FDG uptake in early stage NSCLC.
    Chen JC; Huang TW; Cheng YL; Chang H; Tzao C; Huang WS; Lee SC
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):413-6. PubMed ID: 19795329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology.
    Döbert N; Kovács AF; Menzel C; Hamscho N; Yuen Yuen H; Engels K; Walendzik H; Grünwald F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):253-7. PubMed ID: 16172571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.
    Liu Y
    Nucl Med Commun; 2011 Jul; 32(7):554-62. PubMed ID: 21403583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.
    Shimizu K; Hirami Y; Saisho S; Yukawa T; Maeda A; Yasuda K; Nakata M
    Ann Thorac Surg; 2012 Feb; 93(2):398-403. PubMed ID: 22206958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report.
    Liu RS; Yeh SH; Huang MH; Wang LS; Chu LS; Chang CP; Chu YK; Wu LC
    Eur J Nucl Med; 1995 Dec; 22(12):1402-7. PubMed ID: 8586085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
    Lee HJ; Ahn BC; Hong CM; Song BI; Kim HW; Kang S; Jeong SY; Lee SW; Lee J
    Nuklearmedizin; 2011; 50(5):204-13. PubMed ID: 21727990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Invited commentary.
    Spaggiari L; Casiraghi M; Guarize J
    Ann Thorac Surg; 2013 Jan; 95(1):311. PubMed ID: 23272848
    [No Abstract]   [Full Text] [Related]  

  • 57. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
    Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
    Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
    Nair VJ; MacRae R; Sirisegaram A; Pantarotto JR
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):312-8. PubMed ID: 24411602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reply to Bertolaccini et al.
    Fukumoto K; Yokoi K
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):188-9. PubMed ID: 23341042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.